LAMOND DAVID purchased 2.0% of their position (43.13K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $40.5K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/1/2023ACC: 0001209191-23-057053
+43.13K
Net shares
Net buyer
$40.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
43.13K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+14.38K
Price / share
$0.98
Trade value
$14.09K
% of position
0.7%
11/29/2023
2.18M→2.19M
Common Stock
Indirect
Shares
+14.38K
Price / share
$0.90
Trade value
$12.94K
% of position
0.7%
11/30/2023
2.19M→2.21M
Common Stock
Indirect
Shares
+14.38K
Price / share
$0.94
Trade value
$13.52K
% of position
0.7%
12/1/2023
2.21M→2.22M
Total
Net shares
+43.13K
Net value
$40.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/29/2023 | P · Purchase | +14.38K | $0.98 | $14.09K | 0.7% | 2.18M | 2.19M |
| Common Stock Indirect | 11/30/2023 | P · Purchase | +14.38K | $0.90 | $12.94K | 0.7% | 2.19M | 2.21M |
| Common Stock Indirect | 12/1/2023 | P · Purchase | +14.38K | $0.94 | $13.52K | 0.7% | 2.21M | 2.22M |
| Total | +43.13K | $40.55K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.73M
Common Stock
DirectShares owned301.83K
Total
301.83K direct·1.73M indirect2.04M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.73M | Indirect |
| Common Stock | 301.83K | Direct |
| Total | 2.04M | 301.83K direct·1.73M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported